1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Marcus & Millichap reported third quarter 2025 revenue of $193.9 million, up 15.1% from a year earlier, and net income of $0.2 million, or $0.01 per diluted share, compared with a net loss of $5.4 million a year earlier. The result includes a $0.08 per share litigation accrual, and the company says its financial results are preliminary until it files its Form 10-Q.
Total revenue of $193.9 million, up 15.1% from $168.5 million in Q3 2024
Net income of $0.2 million, or $0.01 per diluted share, versus a net loss of $5.4 million, or $0.14 per share, a year earlier; includes a $0.08 per share litigation accrual
Nine-month net loss narrowed to $15.2 million, or $0.39 per diluted share, from $20.9 million, or $0.54 per share
About $59.0 million remained available under the share repurchase program after repurchases through November 4, 2025
Brighthouse Financial reported third-quarter 2025 net income available to shareholders of $453 million, or $7.89 per diluted share, up from $150 million, or $2.47 per share, a year earlier, including a $316 million net favorable impact from the annual actuarial review. The same day, the company agreed to a definitive merger in which an affiliate of Aquarian Capital LLC will acquire it for $70.00 per share in cash, a transaction valued at about $4.1 billion. The company also canceled its earnings conference call because of the pending deal.
Aquarian Capital affiliate to acquire Brighthouse Financial for $70.00 per share in an all-cash deal valued at about $4.1 billion
Net income available to shareholders of $453 million, or $7.89 per diluted share, versus $150 million, or $2.47, in Q3 2024
Adjusted earnings, less notable items, of $261 million, or $4.54 per diluted share, versus $243 million, or $3.99, in Q3 2024
Estimated combined RBC ratio of 435% to 455%; holding company liquid assets of $1.0 billion as of September 30, 2025
Ziff Davis reported unaudited third-quarter 2025 revenue of $363.7 million, up 2.9% from a year earlier, and GAAP net loss narrowed to $3.6 million from $48.6 million. Adjusted diluted EPS rose 7.3% to $1.76, and the company reaffirmed its 2025 guidance. It also said it has engaged outside advisors to evaluate opportunities, including the potential sale of entire divisions, though no final decisions have been made.
Q3 2025 revenue $363.7 million, up 2.9% from $353.6 million; fifth consecutive quarter of revenue growth
GAAP net loss of $3.6 million, or $(0.09) per diluted share, versus a $48.6 million loss in Q3 2024; both periods include goodwill impairments ($17.6 million in 2025, $85.3 million in 2024)
Adjusted EBITDA was $124.1 million, down 0.5% from $124.7 million; free cash flow rose to $108.2 million from $80.1 million
2025 guidance reaffirmed: revenues $1,442 million to $1,502 million; Adjusted EBITDA $505 million to $542 million; Adjusted diluted EPS $6.64 to $7.28; earnings call Nov. 7, 2025 at 8:30 a.m. ET
Alliant Energy reported third-quarter 2025 GAAP EPS of $1.09, down from $1.15, and ongoing EPS of $1.12, also down from $1.15, while nine-month GAAP EPS rose to $2.59 from $2.10. The company narrowed its 2025 ongoing EPS guidance to $3.17-$3.23, issued 2026 ongoing EPS guidance of $3.36-$3.46, and raised its 2026 dividend target to $2.14 per share, which matters to shareholders because it sets the company's earnings and dividend outlook while raising its capital spending plan.
Q3 2025 GAAP EPS $1.09 vs $1.15; ongoing EPS $1.12 vs $1.15; Q3 revenue $1,210 million vs $1,081 million
Nine months 2025 GAAP EPS $2.59 vs $2.10 (up 23.3%); ongoing EPS $2.62 vs $2.33 (up 12.4%)
2026 ongoing EPS guidance $3.36-$3.46 (6.6% midpoint growth over 2025); 2026 dividend target $2.14 per share vs $2.03
Four-year capital expenditure forecast raised 17% to $13.4 billion; contracted data center demand of 3 GW
Duke Energy reported third-quarter 2025 reported and adjusted EPS of $1.81, up from $1.60 reported and $1.62 adjusted a year earlier, and narrowed its 2025 adjusted EPS guidance to $6.25 to $6.35. The company reaffirmed its long-term adjusted EPS growth rate of 5% to 7% through 2029 and said it expects to announce a new 2026-2030 capital plan of $95 billion to $105 billion in February.
Q3 2025 reported and adjusted EPS of $1.81, versus $1.60 reported and $1.62 adjusted in Q3 2024
2025 adjusted EPS guidance narrowed to $6.25 to $6.35, with a midpoint of $6.30
Long-term adjusted EPS growth rate of 5% to 7% through 2029 reaffirmed
New 2026-2030 capital plan of $95 billion to $105 billion expected to be announced in February
On November 6, 2025, TNMP, an indirect subsidiary of TXNM Energy, entered into a Twenty-Fifth Supplemental Indenture to its First Mortgage Indenture with U.S. Bank Trust Company as trustee. The amendment changes certain financial reporting requirements, revises change-in-control definitions in several earlier supplemental indentures, and adds a covenant to provide financial statements to holders of Fifth Supplemental Indenture bonds. The filing says TNMP obtained the required bondholder consents.
Agreement dated November 6, 2025, supplements the First Mortgage Indenture dated March 23, 2009.
Amends change-in-control definitions in ten earlier supplemental indentures, dated 2019 through 2025.
Adds a covenant to make annual and quarterly TNMP financial statements available to Fifth Supplemental Indenture bondholders, dated April 3, 2013.
The filing does not disclose any dollar amounts or financial results.
Dynamix Corporation III, a blank check company, closed its initial public offering on October 31, 2025, selling 20,125,000 units at $10.00 each for gross proceeds of $201,250,000. The full $201,250,000 was placed in a U.S.-based trust account, and the company has not selected a business combination target. For shareholders, the capital is held in trust until a business combination is completed, the company is liquidated, or shareholders redeem their shares.
IPO closed October 31, 2025: 20,125,000 units at $10.00 each, including 2,625,000 units from the underwriters' full exercise of their over-allotment option, for gross proceeds of $201,250,000.
$201,250,000 ($10.00 per unit) placed in a trust account at J.P. Morgan Chase Bank, N.A., maintained by Odyssey Transfer and Trust Company.
Private placement of 6,275,000 warrants at $1.00 each for gross proceeds of $6,275,000, including 4,262,500 warrants to sponsor DynamixCore Holdings III, LLC.
Company has not selected a business combination target and has 24 months from the IPO closing to complete a business combination.
Sylvamo directors Karl Meyers and Mark Wilde resigned from the board effective November 5, 2025, after Atlas FRM LLC and affiliates delivered resignation notices and waived their right to recommend replacements. The filing says the Atlas cooperation period under the February 14, 2023 agreement will terminate on November 13, 2025, which ends the framework that governed those board seats.
Karl Meyers and Mark Wilde resigned from the Sylvamo board effective November 5, 2025.
Resignations were made under irrevocable letters tied to their initial board appointments under the Cooperation Agreement.
Atlas Group waived its right to recommend substitute directors for either seat.
The Cooperation Period is set to terminate on November 13, 2025.
American Healthcare REIT reported third quarter 2025 net income attributable to its controlling interest of $55.9 million, or $0.33 per diluted share, compared with a loss of $4.1 million a year earlier, and raised its full-year 2025 guidance. The company's full-year NFFO guidance now runs from $1.69 to $1.72 per share, up from $1.64 to $1.68, which gives shareholders a higher expected earnings base for 2025.
Q3 2025 revenue was $572.9 million, up from $523.8 million in Q3 2024; net income attributable to controlling interest was $55.9 million, or $0.33 per diluted share, versus a loss of $4.1 million, or $0.03 per share.
Q3 2025 NFFO was $0.44 per diluted share, compared with $0.36 in Q3 2024.
2025 NFFO guidance was raised to $1.69 to $1.72 per share from $1.64 to $1.68; total portfolio same-store NOI growth guidance was raised to 13.0% to 15.0% from 11.0% to 14.0%.
Net debt to annualized adjusted EBITDA improved to 3.5x as of September 30, 2025, from 3.7x as of June 30, 2025.
Diodes reported third quarter 2025 revenue of $392.2 million, up from $350.1 million a year earlier, and GAAP net income of $14.3 million, or $0.31 per diluted share, compared with $0.30 a year earlier. Non-GAAP EPS fell to $0.37 from $0.43, and the company guided fourth quarter revenue to about $380 million, plus or minus 3 percent, which it says would be 12 percent growth at the midpoint. The results are preliminary and unaudited until the Form 10-Q is filed.
Q3 2025 revenue was $392.2 million, up from $350.1 million in Q3 2024 and $366.2 million in Q2 2025.
GAAP gross margin was 30.7 percent, compared with 33.7 percent a year earlier; the company cited product mix.
Non-GAAP adjusted EPS was $0.37 per diluted share, compared with $0.43 in Q3 2024.
Fourth quarter 2025 guidance: revenue about $380 million, plus or minus 3 percent; GAAP gross margin 31.0 percent, plus or minus 1 percent.
Northrop Grumman's board elected John Greene, former chief financial officer of Discover Financial Services, as corporate vice president and CFO, effective January 7, 2026. Current CFO Ken Crews is stepping down from the role on that date and will serve in an advisory capacity until February 20, 2026. The company reaffirmed its 2025 guidance and 2026 outlook, so the change is a leadership transition with no stated change to financial targets.
John Greene, 60, was elected by the board on November 3, 2025; he will be CFO effective January 7, 2026, and report to CEO Kathy Warden.
Greene's base salary is $955,000, with a sign-on grant of Restricted Stock Rights valued at $2,000,000.
Crews remains CFO through January 7, 2026, then serves in an advisory role until February 20, 2026.
The company reaffirmed its 2025 financial guidance and 2026 outlook, first shared on its October 21 earnings call.
Bread Financial Holdings closed a $500 million offering of 6.750% Senior Notes due 2031 on November 6, 2025, under an indenture with U.S. Bank Trust Company as trustee. The company is adding $500 million of senior unsecured debt, with interest payable semiannually starting May 15, 2026, which increases its fixed borrowing costs for shareholders to consider.
Notes: $500 million principal, 6.750% coupon, maturing May 15, 2031
Interest payable May 15 and November 15 each year, starting May 15, 2026
Company may redeem at any time on or after May 15, 2028 at specified prices; make-whole premium applies before then
Holders may require repurchase at 101% of principal upon a Change of Control Triggering Event
Chesapeake Utilities reported third-quarter 2025 net income of $19.4 million, or $0.82 per diluted share, up from $17.5 million, or $0.78, a year earlier. For the nine months, net income was $94.2 million, or $4.03 per share, compared with $81.9 million, or $3.66. The company reaffirmed its 2025 adjusted EPS guidance of $6.15 to $6.35 but raised its 2025 capital guidance to $425 million to $450 million.
Q3 adjusted gross margin rose $15.2 million, or 12.5%, to $137.2 million; operating income rose $4.1 million, or 10.0%, to $45.0 million.
Q3 adjusted EPS was $0.82 versus $0.80 a year earlier, including a $0.04 per share impact from $92.0 million of equity issued over the last twelve months.
2025 adjusted EPS guidance of $6.15 to $6.35 was reaffirmed, assuming a successful outcome on the FCG Depreciation Study.
The 2025 capital guidance range was increased to $425 million to $450 million, and the 2028 EPS guidance of $7.75 to $8.00 was affirmed.
Globe Life Inc. amended its Supplemental Executive Retirement Plan on November 5, 2025, changing early retirement reduction factors for participants who retire before 65. The amendment also sets benefit terms for participants who suffer a qualifying termination during a change-of-control protection period. The filing does not disclose any financial figures, and the change affects executive pension benefits rather than company results.
Amendment dated November 5, 2025 revises early retirement reduction factors, from 50% at age 55 to 100% at age 65.
Participants in the Executive Severance Plan who have a qualifying termination during a change-of-control protection period are deemed vested and eligible for retirement income.
In those cases, retirement age is deemed at least 55, and no additional credited service is added to pension or SERP benefits.
Heartland Express reported unaudited third-quarter 2025 results, with operating revenue of $196.5 million, down from $259.9 million a year earlier, and a net loss of $8.3 million, compared with $9.3 million in the third quarter of 2024. The operating ratio worsened to 103.7% from 102.7%, and management said it does not expect material market improvement until sometime in 2026.
Operating revenue of $196.5 million, versus $259.9 million in Q3 2024
Net loss of $8.3 million, or $0.11 per basic share, versus $9.3 million, or $0.12 per share, a year earlier
Operating ratio of 103.7%, compared with 102.7% in Q3 2024
Cash of $32.7 million at September 30, 2025; repurchased $1.4 million of common stock in the quarter
V2X, Inc. said it has appointed Daniel G. Demases as its new Chief Accounting Officer, replacing William B. Noon, effective December 5, 2025. The offer letter sets a $335,500 base salary and a target short-term cash incentive of 45% of base salary, and the company said it will recommend a $180,000 target long-term award for calendar 2026.
Daniel G. Demases succeeds William B. Noon as Chief Accounting Officer, effective December 5, 2025.
Annual base salary of $335,500; short-term cash incentive target of 45% of base salary, with a maximum of 90%.
For calendar 2026, a recommended long-term target award of $180,000, split 50% time-vesting restricted stock units and 50% performance stock units.
Con Edison reported third-quarter 2025 net income for common stock of $688 million, or $1.91 a share, up from $588 million, or $1.70 a share, a year earlier. It narrowed its 2025 adjusted earnings per share forecast to $5.60 to $5.70, from $5.50 to $5.70, and said the company's utility subsidiary reached a joint settlement on a three-year rate plan that still needs regulatory approval.
Q3 2025 net income for common stock was $688 million ($1.91 a share) vs. $588 million ($1.70 a share) in Q3 2024; adjusted EPS was $1.90 vs. $1.68.
Nine-month 2025 GAAP net income was $1,726 million ($4.84 a share) vs. $1,510 million ($4.37 a share); nine-month adjusted EPS was $4.82 vs. $4.42.
2025 adjusted EPS guidance is $5.60 to $5.70, up from $5.50 to $5.70 at the low end, and the company described it as narrowed to the upper half of the original range.
The CECONY joint proposal covers January 2026 through December 2028 and assumes a 9.40% return on equity and 48% equity ratio, subject to New York State Public Service Commission approval.
Mettler-Toledo reported third-quarter 2025 sales up 8% to $1,029.7 million and diluted EPS of $10.57, compared with $9.96 a year earlier. The company raised its full-year 2025 adjusted EPS forecast to $42.05 to $42.25 from $42.20 at the top end of the prior range of $41.70 to $42.20, and authorized an additional $2.75 billion for share repurchases.
Q3 2025 adjusted EPS was $11.15, up 9% from $10.21; GAAP diluted EPS was $10.57 versus $9.96.
Full-year 2025 local currency sales growth is forecast at approximately 2%, and adjusted EPS at $42.05 to $42.25 versus prior guidance of $41.70 to $42.20.
The Board added $2.75 billion to the share repurchase program, which had $1.1 billion remaining as of September 30, 2025.
For the fourth quarter, adjusted EPS is forecast at $12.68 to $12.88, which includes an estimated 7% gross headwind from higher tariff costs.
Concentra Group Holdings reported third-quarter 2025 revenue of $572.8 million, up 17.0% from a year earlier, and net income of $49.8 million, up 8.9%. The company raised its full-year 2025 guidance and authorized a $100 million share repurchase program. For the nine months, net income fell 8.3% to $136.7 million, which the company attributed to higher interest expense from its IPO recapitalization.
Q3 2025 revenue of $572.8 million, up 17.0% from $489.6 million; net income of $49.8 million, up 8.9%
Q3 earnings per share of $0.38, compared with $0.37 in Q3 2024
Raised 2025 guidance: revenue of $2.145 billion to $2.160 billion and Adjusted EBITDA of $425 million to $430 million
Board authorized a $100 million share repurchase program expiring December 31, 2027, and declared a $0.0625 per share dividend payable December 9, 2025
Mueller Water Products said CEO Marietta Zakas will retire as CEO and board member effective February 9, 2026, and President and COO Paul McAndrew will succeed her. Zakas will serve as a Senior Advisor through December 31, 2026 under a transition agreement, and the company also reported that it will release fourth quarter and fiscal 2025 results on November 7, 2025.
Paul McAndrew, President and COO since May 2024, becomes President and CEO on February 9, 2026, and will be nominated to the Board at the annual shareholders meeting.
McAndrew's letter agreement sets a base salary of $915,000, a target annual bonus of 100% of base salary and a target long-term incentive of 370% of base salary.
Zakas's transition agreement includes a prorated fiscal 2026 bonus, a performance-based RSU award with a $2,000,000 grant date value and benefits, subject to a release of claims.
Mueller's earnings conference call on fiscal fourth quarter and full-year 2025 results is set for Friday, November 7, 2025, at 10:00 a.m. ET.
Victory Capital reported third-quarter 2025 results on November 6, 2025, with revenue of $361.2 million, up 60.1% from a year earlier. The company attributes the higher revenue to higher average assets under management following its April 1, 2025 acquisition of Amundi US. GAAP diluted EPS was $1.11, down from $1.24 a year earlier, while adjusted net income with tax benefit per diluted share rose to $1.63 from $1.35.
Revenue of $361.2 million, up 60.1% from $225.6 million a year earlier and up 2.8% from $351.2 million in the second quarter.
GAAP net income of $96.5 million, up 17.8% from $82.0 million; GAAP operating margin of 38.2%, down from 53.3%.
GAAP diluted EPS of $1.11 versus $1.24 a year earlier; adjusted net income with tax benefit per diluted share of $1.63 versus $1.35.
Board approved a regular quarterly cash dividend of $0.49 per share, payable December 23, 2025, to holders of record on December 10, 2025.
Camden Property Trust reported third quarter 2025 EPS of $1.00 per diluted share, compared with a loss of $0.04 a year earlier, and FFO of $1.67 versus $1.65. Core FFO was $1.70 per share, slightly below $1.71 a year earlier, and the company raised the midpoint of its 2025 Core FFO guidance to $6.85 from $6.81. For shareholders, the higher guidance reflects better-than-expected third quarter results and expected fourth quarter benefits from acquisition and disposition timing and lower borrowing costs.
Q3 2025 EPS was $1.00 per diluted share versus a loss of $0.04 in Q3 2024; nine-month EPS was $2.10 versus $1.13
Q3 2025 Core FFO was $1.70 per share versus $1.71 a year earlier; Core AFFO was $1.43 versus $1.48
2025 Core FFO guidance midpoint raised to $6.85 from $6.81; 2025 EPS guidance midpoint raised to $2.44 from $2.38
Same property NOI growth was 0.0% in Q3 2025 versus Q3 2024; 2025 same property NOI guidance midpoint was maintained at 0.25%
ePlus reported second-quarter fiscal 2026 net sales of $608.8 million, up 23.4%, and net earnings from continuing operations of $38.2 million, up 92.7%, and it raised its fiscal 2026 guidance for net sales, gross profit and Adjusted EBITDA. A $3.3 million loss from discontinued operations, tied to a $4.6 million contingent liability from the sold domestic financing business, partly offset these results. The board also declared a quarterly cash dividend of $0.25 per share.
Second-quarter net sales rose 23.4% to $608.8 million and gross profit rose 27.4% to $162.1 million.
Diluted EPS from continuing operations was $1.45, compared with $0.74 a year earlier.
Fiscal 2026 net sales are now expected to grow in the mid-teens from $2.01 billion in fiscal 2025.
The $0.25 dividend is payable December 17, 2025, to shareholders of record on November 25, 2025.
Chemours reported third quarter 2025 net sales of $1.5 billion, flat year over year, and net income attributable to Chemours of $60 million, or $0.40 per diluted share, compared with a net loss of $32 million a year earlier. Adjusted net income fell to $30 million, or $0.20 per diluted share, from $61 million, and adjusted EBITDA declined to $195 million from $202 million. For fourth quarter 2025, the company expects adjusted EBITDA of $130 million to $160 million on sequentially lower net sales, which would be below the third quarter level.
Net sales of $1,495 million, down 1% from $1,508 million in Q3 2024; Thermal & Specialized Solutions sales rose 20% to $560 million
Net income attributable to Chemours of $60 million ($0.40 per diluted share) vs. a net loss of $32 million ($0.22) in Q3 2024; adjusted net income of $30 million ($0.20 per share) vs. $61 million ($0.40)
Fourth quarter 2025 outlook: net sales expected to fall 10% to 15% sequentially; adjusted EBITDA expected between $130 million and $160 million
Liquidity of $1.6 billion at September 30, 2025, including $613 million in unrestricted cash; net leverage ratio of approximately 4.6x
Two National Health Investors board members, Robert G. Adams and Charlotte A. Swafford, notified the board on November 5, 2025, that they will leave the board in 2026. Both said their decisions were not due to any disagreement with the company on operations, policies or practices.
Robert G. Adams will not stand for reelection; his term ends at the 2026 annual meeting of stockholders.
Charlotte A. Swafford will retire from the board effective May 27, 2026, immediately before the 2026 Annual Meeting.
The filing states neither departure stemmed from a disagreement with the company.
On November 4, 2025, New Jersey Resources' compensation committee approved its fiscal 2026 Officer Annual Incentive Plan and granted long-term equity awards to its named executive officers. The awards tie pay to net financial earnings, total shareholder return, and cumulative net financial earnings per share over fiscal 2026 through fiscal 2028.
Annual incentive awards are 50 percent based on fiscal 2026 net financial earnings, 30 percent on individual leadership, and 20 percent on Commitment to Stakeholders goals.
CEO target incentive is 110 percent of base salary; other named executive officers range from 40 to 60 percent.
Performance share units vest after a 36-month period ending September 30, 2028, with payouts from zero to 150 percent of the granted units.
DNOW completed its acquisition of MRC Global on November 6, 2025, converting each MRC Global common share into the right to receive 0.9489 DNOW common shares. The company also amended its asset-based credit facility, extending maturity to November 30, 2030 and setting an $850 million revolver with an accordion feature of up to $500 million more. Shareholders will face a larger share count and a combined company whose earnings and cost synergies have not yet been reported in this filing.
Each MRC Global common share converted into the right to receive 0.9489 DNOW common shares, with cash paid for fractional shares.
Amended credit facility has an $850 million revolver, with an accordion permitting up to $500 million more (total commitments of up to $1.35 billion) and a maturity of November 30, 2030.
DNOW expects $70 million of annual cost synergies within three years following closing.
George J. Damiris and Ronald L. Jadin joined the Board, which was expanded to ten members; Gillian Anderson was appointed Vice President and Chief Accounting Officer.
Silgan Holdings elected Shawn C. Fabry as Executive Vice President and Chief Financial Officer effective November 6, 2025, as part of continued succession planning. Former CFO Kimberly Ulmer moved to Senior Vice President and Chief Accounting Officer, and Robert B. Lewis announced plans to retire as an employee effective March 31, 2026 while remaining a director.
Shawn C. Fabry, age 48, named CFO effective November 6, 2025; he most recently served as Senior Vice President, Corporate Development
Kimberly I. Ulmer, age 58, moved from CFO to Senior Vice President and Chief Accounting Officer
Robert B. Lewis to retire as Executive Vice President, Corporate Development and Administration effective March 31, 2026, and will continue as a director
Alexander G. Hutter, age 40, named Senior Vice President, Strategy and Investor Relations
HCI Group reported third-quarter 2025 pre-tax income of $90.6 million and diluted earnings per share of $4.90, compared with $14.1 million and $0.52 a year earlier. The company said the gain reflects higher premiums and lower catastrophe-related losses, and that book value per share rose to $63.41 from $43.45. The company also said the separation of Exzeo as an independent, publicly traded entity was completed earlier in the week.
Third-quarter pre-tax income was $90.6 million versus $14.1 million; net income after noncontrolling interests was $65.5 million versus $5.7 million.
Diluted EPS was $4.90 versus $0.52 in the third quarter of 2024.
Gross premiums earned rose 13.4% to $301.1 million; the gross loss ratio fell to 22.0% from 39.8%, reflecting lower catastrophic event activity.
Book value per share was $63.41 at September 30, 2025, versus $43.45 a year earlier.
Arlo Technologies reported third-quarter 2025 revenue of $139.5 million, up from $137.7 million a year earlier, and GAAP net income of $6.9 million, compared with a net loss of $4.4 million in the same quarter of 2024. The company also gave a fourth-quarter revenue outlook of $131 million to $141 million, with GAAP diluted EPS of $0.00 to $0.06 and non-GAAP diluted EPS of $0.13 to $0.19.
Q3 revenue $139.5 million, versus $137.7 million a year earlier; subscriptions and services revenue $79.9 million, up 29.2% year over year
Q3 GAAP net income $6.9 million, or $0.07 basic EPS; non-GAAP diluted EPS $0.16, versus $0.11 a year earlier
Annual recurring revenue (ARR) of $323.2 million, up 33.8% year over year; adjusted EBITDA $17.1 million
Q4 2025 outlook: revenue $131 million to $141 million; GAAP diluted EPS $0.00 to $0.06; non-GAAP diluted EPS $0.13 to $0.19
Block reported third-quarter 2025 results, with gross profit of $2.66 billion, up 18% year over year, and GAAP net income of $462 million. The company raised its full-year 2025 guidance, now expecting gross profit of $10.243 billion and Adjusted Operating Income of $2.056 billion. Shareholders get higher expected profit for 2025, though Adjusted Diluted EPS of $0.54 rose only 2% year over year.
Q3 2025 gross profit was $2.66 billion, up 18% year over year; Cash App gross profit rose 24% and Square gross profit rose 9%.
GAAP diluted EPS was $0.74 versus $0.45 a year earlier; Adjusted Diluted EPS was $0.54 versus $0.53.
Full-year 2025 guidance: gross profit of $10.243 billion and Adjusted Operating Income of $2.056 billion.
Q4 2025 guidance: gross profit of $2.755 billion and Adjusted Operating Income of $560 million.
Assured Guaranty reported third quarter 2025 GAAP net income of $105 million, or $2.18 per diluted share, down from $171 million, or $3.17, a year earlier. Adjusted operating income rose to $2.57 per share from $2.42, while total adjusted operating income fell to $124 million from $130 million, and the Board authorized an additional $100 million of share repurchases.
GAAP net income attributable to Assured Guaranty was $105 million, or $2.18 per diluted share, in Q3 2025, versus $171 million, or $3.17, in Q3 2024.
Adjusted operating income was $124 million, or $2.57 per share, versus $130 million, or $2.42, in Q3 2024.
The Company repurchased $118 million of shares in Q3 2025, and its Board authorized an additional $100 million on November 5, 2025.
Shareholders' equity attributable to Assured Guaranty per share was $121.13 as of September 30, 2025, up from $108.80 at December 31, 2024.
PDF Solutions reported third quarter 2025 results on November 6, 2025, with total revenue of $57.1 million, up 23% from $46.4 million a year earlier. GAAP net income fell to $1.3 million, or $0.03 per diluted share, from $2.2 million, or $0.06, in the third quarter of 2024, while non-GAAP diluted EPS was flat at $0.25. CEO John Kibarian said the company reaffirmed its prior 21-23% annual revenue growth guidance for 2025.
Q3 2025 revenue of $57.1 million, up 23% from Q3 2024 and up from $51.7 million in Q2 2025
GAAP net income of $1.3 million, or $0.03 per diluted share, versus $2.2 million, or $0.06, a year earlier
Non-GAAP diluted EPS of $0.25, unchanged from Q3 2024; ending backlog of $292.0 million
Management reaffirmed 21-23% annual revenue growth guidance for 2025
Alamo Group reported third quarter 2025 net sales of $420.0 million, up 4.7% from a year earlier, while income from operations fell 6.3% to $37.5 million and diluted EPS fell to $2.10 from $2.28. Adjusted diluted EPS was $2.34 versus $2.38, and adjusted EBITDA was flat at $55.0 million. Shareholders see higher sales offset by lower profit, with the Industrial Equipment Division growing and the Vegetation Management Division declining.
Net sales rose 4.7% to $420.0 million; Industrial Equipment Division sales rose 17.0% to $247.0 million, while Vegetation Management Division sales fell 9.0% to $173.1 million.
Diluted EPS was $2.10, down $0.18 from $2.28; adjusted diluted EPS was $2.34, down $0.04 from $2.38.
Operating cash flow for the first nine months of 2025 was $102.4 million; total debt was $209.4 million and cash was $244.8 million at September 30, 2025.
The company will host a conference call on Friday, November 7, 2025, at 10:00 a.m. ET to discuss the results.
Monster Beverage reported third-quarter 2025 results that set records for net sales, gross profit, operating income and net income, according to the company. Net income rose 41.4% to $524.5 million, and diluted earnings per share rose to $0.53 from $0.38, which means shareholders saw higher profit per share in the quarter. The filing also states that the company repurchased no shares in the quarter, with about $500.0 million still available under its repurchase program.
Q3 net sales rose 16.8% to $2.20 billion from $1.88 billion a year earlier; the Monster Energy Drinks segment grew 17.7% to $2.03 billion.
Q3 operating income rose 40.7% to $675.4 million; gross profit as a percentage of net sales rose to 55.7% from 53.2%.
Q3 net income rose 41.4% to $524.5 million; diluted EPS was $0.53 versus $0.38.
No shares were repurchased in Q3 2025; about $500.0 million remained available for repurchase as of November 5, 2025.
Flowers Foods reported third-quarter 2025 net sales up 3.0% to $1.227 billion, helped by the Simple Mills acquisition, while net income fell 39.2% to $39.5 million on a challenging consumer environment and higher interest expense. The company narrowed its fiscal 2025 outlook, with adjusted diluted EPS now expected at $1.02 to $1.08 versus prior guidance of $1.00 to $1.10.
Q3 net sales rose 3.0% to $1.227 billion; pricing/mix fell 2.3% and volume fell 0.6%, while Simple Mills added 5.9%.
Diluted EPS fell $0.12 to $0.19; adjusted diluted EPS fell $0.10 to $0.23.
Adjusted EBITDA fell 11.4% to $118.1 million; net interest expense rose $9.7 million, tied to debt issued to fund the Simple Mills acquisition.
Fiscal 2025 adjusted EBITDA guidance is $515 million to $532 million, versus prior $512 million to $538 million; live webcast is set for 8:30 a.m. Eastern on November 7, 2025.
EOG Resources reported third quarter 2025 results on November 6, 2025, with total operating revenues and other of $5.8 billion, net income of $1.5 billion, and diluted earnings of $2.70 per share. Compared with the second quarter of 2025, revenue and net income rose, but both remained below third quarter 2024 levels, when net income was $1.7 billion and diluted earnings were $2.95 per share. The release also includes a fourth quarter and full year 2025 forecast, which is not contained in the portion of the filing reviewed here.
Total operating revenues and other were $5,847 million in Q3 2025, up from $5,478 million in Q2 2025 and down from $5,965 million in Q3 2024.
Net income was $1,471 million, or $2.70 per diluted share, versus $1,345 million ($2.46) in Q2 2025 and $1,673 million ($2.95) in Q3 2024.
Adjusted net income (non-GAAP) was $1,472 million, or $2.71 per diluted share, compared with $2.89 per diluted share in Q3 2024.
The fourth quarter and full year 2025 forecast and benchmark commodity prices are in Exhibit 99.1 and Item 7.01; the figures are not included in the text reviewed.
Saul Centers reported third-quarter 2025 revenue of $72.0 million, up from $67.3 million a year earlier, but net income fell to $14.0 million from $19.6 million. The company said the initial operations of Twinbrook Quarter Phase I, which began charging interest, taxes and other costs to expense, reduced net income by $4.7 million, and net income available to common stockholders dropped to $0.32 per share from $0.48.
Total revenue was $72.0 million for the quarter ended September 30, 2025, versus $67.3 million a year earlier.
Net income available to common stockholders was $7.7 million, or $0.32 per basic and diluted share, versus $11.7 million, or $0.48, in the prior-year quarter.
Twinbrook Quarter Phase I reduced net income by $4.7 million, of which $4.6 million was lower capitalized interest.
FFO available to common stockholders and noncontrolling interests was $25.3 million, or $0.72 per share, versus $28.9 million, or $0.84 basic, a year earlier.
Amphastar reported third-quarter 2025 net revenues of $191.8 million, roughly flat from $191.2 million a year earlier. GAAP diluted EPS fell to $0.37 from $0.78, and the company said general and administrative expenses rose mainly because of a $23.1 million litigation provision. Adjusted non-GAAP diluted EPS was $0.93, compared with $0.96 a year earlier.
Net revenues were $191.8 million, up $626 thousand (0%) from $191.2 million in the third quarter of 2024.
GAAP net income was $17.4 million, down from $40.4 million; GAAP diluted EPS was $0.37 versus $0.78.
Adjusted non-GAAP diluted EPS was $0.93 versus $0.96; the adjustments include a $23.1 million litigation provision.
BAQSIMI sales rose 33% to $53.6 million, while glucagon sales fell 49% to $13.6 million.
Celanese reported a third-quarter U.S. GAAP diluted loss of $12.39 per share, driven by about $1.5 billion in Certain Items, mainly non-cash impairments in Engineered Materials. Adjusted EPS was $1.34, down from $2.41 a year earlier, and net sales fell to $2.4 billion. The company guided fourth-quarter adjusted EPS to $0.85 to $1.00 and agreed to sell its Micromax business for about $500 million to deleverage the balance sheet.
Q3 net sales were $2.4 billion, down 4% sequentially and from $2.6 billion a year earlier; adjusted EPS was $1.34 versus $2.41 in Q3 2024.
Certain Items totaled $1.5 billion, principally non-cash asset impairment losses in the Engineered Materials segment.
Q4 2025 adjusted EPS is expected to be $0.85 to $1.00, with volume declines expected from western hemisphere seasonality.
Micromax divestiture to Element Solutions Inc. at about $500 million is expected to close in Q1 2026; Q3 free cash flow was $375 million.
QuinStreet reported fiscal first-quarter 2026 results for the period ended September 30, 2025, with revenue of $285.9 million and GAAP net income of $4.5 million, compared with a net loss of $1.4 million a year earlier. The Board also authorized a new $40 million share repurchase program and gave outlook for fiscal Q2 and full-year fiscal 2026.
Revenue of $285.9 million, up 2% year-over-year; Financial Services $207.5 million and Home Services $78.4 million
GAAP net income of $4.5 million, or $0.08 per diluted share, versus a net loss of $1.4 million a year earlier; adjusted EBITDA of $20.5 million, up 1%
Outlook: fiscal Q2 revenue of $270 million to $280 million and adjusted EBITDA of $19 million to $20 million; full-year fiscal 2026 revenue growth of at least 10% and adjusted EBITDA growth of at least 20%
New $40 million share repurchase program; cash of $101.3 million and no bank debt at quarter end
Certara reported third-quarter 2025 revenue of $104.6 million, up 10% from a year earlier, and swung to net income of $1.5 million from a net loss of $1.4 million. The company raised its 2025 profitability targets and narrowed full-year revenue guidance to $415 million to $420 million, though services bookings fell 9% and management cited spending hesitancy in parts of the services business.
Q3 2025 revenue was $104.6 million, up 10%; software revenue rose 22% to $43.8 million and services revenue rose 3% to $60.8 million
Q3 net income was $1.5 million, or $0.01 per diluted share, versus a net loss of $1.4 million a year earlier; adjusted EBITDA was $35.2 million, up 7%
Full-year 2025 guidance: revenue of $415 million to $420 million, adjusted EBITDA margin of about 32%, and adjusted diluted EPS of $0.45 to $0.47
Q3 services bookings were $55.8 million, down 9% year over year, mainly from softer tier-one customer trends in regulatory services
Karman Space & Defense reported third-quarter 2025 revenue of $121.8 million, up 41.7% from a year earlier, and net income of $7.6 million, up 78.1%. The company raised and narrowed its full-year 2025 revenue and adjusted EBITDA guidance, which gives shareholders a higher expected range for the year.
Q3 2025 revenue was $121.8 million, up 41.7% year over year; net income was $7.6 million, or $0.06 per diluted share
Full-year 2025 revenue guidance raised to $461 million to $463 million, from $452 million to $458 million
Full-year 2025 non-GAAP adjusted EBITDA guidance raised to $142 million to $143 million, from $138.5 million to $141.5 million
Preliminary 2026 revenue growth expectation of 20% to 25%, excluding future acquisitions
National Fuel Gas amended its Term Loan Agreement and Credit Agreement on November 6, 2025, changing the definition of "Consolidated Indebtedness" so the company can defease its obligations under the Seller Note Agreement after closing its acquisition of Vectren Energy Delivery of Ohio from CenterPoint Energy Resources. The Seller Note Agreement is the $1.2 billion unsecured term loan the company plans to use to finance part of the purchase price. The filing describes the amendments as facilitating the defeasance and does not report any financial results or cost figures.
On November 6, 2025, the company entered into Amendment No. 1 to its Term Loan Agreement dated February 14, 2024, with JPMorgan Chase Bank as administrative agent.
The company also entered into Amendment No. 2 to its Credit Agreement dated February 28, 2022, as amended May 3, 2022, with JPMorgan Chase Bank as administrative agent.
The acquisition under the October 20, 2025 Securities Purchase Agreement will be partly financed by a $1.2 billion Seller Note Agreement at closing.
The amendments modify the definition of "Consolidated Indebtedness" to allow defeasance of Seller Note obligations after the transaction closes.
Alarm.com reported third-quarter 2025 results on November 6, 2025, with total revenue up 6.6% to $256.4 million and SaaS and license revenue up 10.1% to $175.4 million. GAAP net income fell slightly to $35.1 million, and diluted earnings per share were $0.65, down from $0.67 a year earlier. The company raised its full-year 2025 SaaS and license revenue guidance to $685.2 million to $685.4 million.
Q3 2025 total revenue rose 6.6% to $256.4 million, versus $240.5 million in Q3 2024.
GAAP net income was $35.1 million, compared with $36.5 million; diluted EPS was $0.65, compared with $0.67.
Non-GAAP adjusted EBITDA rose 18.4% to $59.2 million, compared with $50.0 million.
Full-year 2025 SaaS and license revenue guidance is now $685.2 million to $685.4 million, up $4.1 million from the prior midpoint.
Qnity Electronics estimated third-quarter 2025 net sales of $1.3 billion, up 11% from the prior year period, and estimated GAAP net income of about $220 million, up about 6%. The company raised its 2025 net sales estimate to about $4.7 billion from about $4.6 billion and reaffirmed its 2025 adjusted pro forma operating EBITDA estimate of about $1.4 billion, while the quarterly figures remain preliminary and unaudited pending the Form 10-Q.
Q3 2025 net sales of $1.3 billion, up 11%, driven by AI demand across advanced nodes, advanced packaging and thermal management
Estimated GAAP net income of about $220 million, up about 6%; pro forma and management adjusted net income of $155 million, up 16%
Adjusted pro forma operating EBITDA up about 6%, with margin of about 29% versus 30% a year earlier
2025 net sales estimate raised to about $4.7 billion; adjusted pro forma operating EBITDA of about $1.4 billion reaffirmed
National Health Investors reported third-quarter 2025 results on November 6, 2025, with diluted net income per share attributable to common stockholders of $0.69, up from $0.65 a year earlier, and total revenues of $89.8 million, up from $82.9 million. The company raised its full-year 2025 guidance, with Normalized FFO per diluted share now expected at $4.88 to $4.91, up from $4.78 to $4.82, and said this was the third guidance increase this year.
Q3 2025 diluted EPS was $0.69 versus $0.65 in Q3 2024; nine-month diluted EPS was $2.22 versus $2.17.
Q3 2025 Normalized FFO per diluted share was $1.32 versus $1.03; NAREIT FFO per diluted share was $1.09 versus $1.03.
Q3 results include $12.1 million in write-offs of straight-line rents receivable tied to early lease terminations.
2025 guidance: NAREIT FFO per diluted share raised to $4.62 to $4.65 from $4.46 to $4.50; Normalized FFO per diluted share raised to $4.88 to $4.91 from $4.78 to $4.82.
Fidelity National Financial reported third-quarter 2025 results on November 6, 2025, with net earnings attributable to common shareholders of $358 million, or $1.33 per diluted share, up from $266 million, or $0.97 per share, a year earlier. Adjusted net earnings were $439 million, or $1.63 per share, compared with $356 million, or $1.30 per share, and total revenue rose to $4.03 billion from $3.60 billion. The company also repurchased 631,000 shares for $37.5 million and paid $135 million in common dividends during the quarter.
Net earnings of $358 million ($1.33 per diluted share) vs. $266 million ($0.97) in Q3 2024
Adjusted net earnings of $439 million ($1.63 per share) vs. $356 million ($1.30) in Q3 2024
Title Segment adjusted pre-tax margin of 17.8% vs. 15.9%; F&G gross sales of $4.2 billion
Conference call scheduled for Friday, November 7, 2025, at 11:00 a.m. Eastern Time
F&G Annuities & Life reported third-quarter 2025 GAAP net earnings to common shareholders of $114 million, or $0.85 per diluted share, compared with a net loss of $10 million, or $0.08 per share, a year earlier. Adjusted net earnings were $165 million, or $1.22 per share, unchanged from the prior-year quarter, while nine-month adjusted net earnings fell to $359 million from $403 million. The company also reported record assets under management before flow reinsurance of $71.4 billion.
Q3 2025 GAAP net earnings to common shareholders: $114 million ($0.85 per diluted share), versus a $10 million loss ($0.08 per share) in Q3 2024
Q3 2025 adjusted net earnings: $165 million ($1.22 per share), versus $156 million ($1.22 per share) in Q3 2024
Record AUM before flow reinsurance of $71.4 billion, up 14% year over year; Q3 net sales of $2.8 billion versus $2.4 billion
Book value per common share excluding AOCI was $44.07 at September 30, 2025, and the company returned $33 million to shareholders through dividends in the quarter
U.S. Physical Therapy reported third-quarter 2025 results, with physical therapy revenue up 17.8% to $168.1 million and net income attributable to shareholders rising to $13.1 million, or $0.48 per share, from $6.6 million, or $0.39 per share, a year earlier. Management reaffirmed its full-year 2025 Adjusted EBITDA guidance of $93.0 million to $97.0 million and declared a $0.45 quarterly dividend.
Physical therapy revenue rose 17.8% to $168.1 million; patient visits rose 18.0% to 1,554,207.
Net income attributable to USPH shareholders was $13.1 million ($0.48 per share) vs. $6.6 million ($0.39 per share) a year earlier.
Operating Results, a non-GAAP measure, fell to $10.1 million ($0.66 per share) from $10.4 million ($0.69 per share).
Full-year 2025 Adjusted EBITDA guidance of $93.0 million to $97.0 million was reaffirmed; $0.45 dividend payable December 12, 2025 to holders of record November 17, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.